Skip to content

In this study we will see effects of melatonin tablets on S100B protein in delirium patients

"Effects of exogenous melatonin on inflammatory protein (S100B) of delirium and its clinical correlation- a case control study" - DELSM

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/12/022200
Enrollment
60
Registered
2019-12-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F05- Delirium due to known physiological condition

Interventions

Intervention1: Melatonin: Melatonin is essential for delirium. It helps to reset the sleep cycle in delirium. Melatonin tablets will be given to the delirium patients. Dose range is 3-9 mg as per requ

Sponsors

King Georges Medical University
Lead Sponsor
King Georges Medical University
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosis of Delirium qualifying according to ICD-10 (international classification of disease-10). 2. Age 60-95 years 3. Patientâ??s family members willing to give consent.

Exclusion criteria

Exclusion criteria: 1. Past history of seizure, ischemic or haemorrhagic CVA or traumatic brain injury and encephalitis. 2. IQCODE score >= 3.5 to exclude dementia. 3. Unreliable informants.

Design outcomes

Primary

MeasureTime frame
S100B is a calcium binding protein which increases in delirium. Melatonin is a important neurotransmitter which is essential for sleep induction. The hypothesis that melatonin decreases the S100B protein and might be useful for the treatment of delirium.Timepoint: SEVEN DAYS

Secondary

MeasureTime frame
1.To study the severity of delirium before and after giving exogenous melatonin. 2.To study the relation between S100B protein level and the severity of delirium. Timepoint: SEVEN DAYS

Countries

India

Contacts

Public ContactMithun Biswas

King Georges Medical University

shrikantsrivastava@kgmcindia.edu9621373167

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026